XML 44 R37.htm IDEA: XBRL DOCUMENT
v3.25.3

Agreements (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Asset Acquisition [Line Items] |
Schedule Of Total Purchase Price Was Allocated To The Acquired Assets Based On Their Relative Fair Values | The total purchase price was allocated to the acquired assets based on their relative fair values, as follows (in thousands):
License and acquired intangibles |  | $ | 33,569 |
Acquired research and development inventory expensed from asset acquisition |  |  | 4,130 |
Total purchase price |  | $ | 37,699 |
Summary of Aggregate Amount Paid for the Assets Acquired | The following table summarizes the aggregate amount paid for the assets acquired by the Company in connection with the acquisition of FYCOMPA® (in thousands):
Base cash payment |  | $ | 160,000 |
Cash paid for pro-rated prepaid expenses |  |  | 1,576 |
Reimbursement on base purchase price(i) |  |  | (3,238 | )
Transaction costs(ii) |  |  | 5,870 |
Total purchase consideration |  | $ | 164,208 |
(i) Recorded in prepaid expenses and other current assets in the accompanying consolidated balance sheet as of the acquisition date and reimbursement was fully applied as of June 30, 2023. (ii) As of September 30, 2023, the full $5.9 million was paid in cash.
Summary of Total Purchase Price Allocated to Acquired Assets | The total purchase price was allocated to the acquired assets based on their relative fair values, as follows (in thousands):
Inventory |  | $ | 4,100 |
Prepaid expenses and other current assets (samples) |  |  | 130 |
Prepaid commercialization expenses |  |  | 1,576 |
Property and equipment, net |  |  | 433 |
License and acquired intangibles for FYCOMPA® |  |  | 158,143 |
Accrued preclinical and clinical trial expenses |  |  | (174 | )
Total purchase consideration |  | $ | 164,208 |
AGAMREE [Member] |
Asset Acquisition [Line Items] |
Summary of Aggregate Amount Paid for the Assets Acquired | The following table summarizes the aggregate amount paid for the assets acquired by the Company in connection with the acquisition of AGAMREE® and the strategic equity investment (in thousands):
Initial cash payment |  | $ | 75,000 |
Investment in Santhera |  |  | 13,465 |
Transaction costs |  |  | 6,513 |
Total purchase consideration |  | $ | 94,978 |
Summary of Total Purchase Price Allocated to Acquired Assets | The total purchase price was allocated to the acquired assets based on their relative fair values, as follows (in thousands):
License and acquired intangibles for AGAMREE® (IPR&D) |  | $ | 81,513 |
Investment in Santhera(i) |  |  | 13,465 |
Total purchase consideration |  | $ | 94,978 |
(i) The fair value of the investment in Santhera was determined based on the closing market price (CHF 8.25) of Santhera shares and the exchange rate (1.1537) of CHF to USD on the date the shares were transferred, July 19, 2023.

X
- Definition Schedule of total purchase price was allocated to acquire assets. + References No definition available. + Details
Name: | cprx_ScheduleOfTotalPurchasePriceWasAllocatedToAcquireAssetsTableTextBlock
Namespace Prefix: | cprx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of total purchase price was allocated to the acquired assets based on their relative fair values. + References No definition available. + Details
Name: | cprx_ScheduleOfTotalPurchasePriceWasAllocatedToTheAcquiredAssetsBasedOnTheirRelativeFairValuesTableTextBlock
Namespace Prefix: | cprx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of asset acquisition. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=cprx_AgamreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |